Gennex Labs Approves Director Regularization at EGM
Gennex Laboratories Limited conducted an electronic Extraordinary General Meeting on May 12, 2026, to approve the regularization of Ms. Khushbu Kachhawa as a Non-Executive Independent Woman Director. The resolution was passed with 99.9997% of the total votes polled, with 31,176,049 shares voting in favor and 87 against.

*this image is generated using AI for illustrative purposes only.
Gennex Laboratories Limited held an electronic Extraordinary General Meeting (eEGM) on May 12, 2026, through Video Conferencing (VC) and Other Audio Visual Means (OAVM). The meeting was convened to transact special business regarding the regularization of an Additional Director. The proceedings commenced at 12:30 p.m. and concluded at 01:18 p.m., complying with relevant Ministry of Corporate Affairs and SEBI circulars. A total of 47 members attended the meeting via VC, satisfying the requisite quorum.
Voting Results
Shareholders approved the sole resolution on the agenda with an overwhelming majority. The resolution sought the regularization of Ms. Khushbu Kachhawa (DIN: 10872432) as a Non-Executive Independent Woman Director. This appointment was necessary to comply with SEBI (LODR) Regulations, which require the regularization of an Additional Director within three months of their appointment.
The voting process included remote e-voting, which was open from May 8 to May 11, 2026, and e-voting during the meeting. Ms. Sweety Kapoor, Practising Company Secretary, served as the Scrutinizer for the process.
| Resolution | Votes For | Votes Against | % For |
|---|---|---|---|
| Regularization of Director Ms. Khushbu Kachhawa | 31,176,049 | 87 | 99.9997 |
Meeting Participation
A total of 91 members participated in the voting process through remote e-voting and during the EGM. The total number of votes cast was 31,176,136. Promoter and Promoter Group held 57,405,624 shares, while Public Non-Institutions held 185,542,050 shares as on the record date of May 1, 2026.
The Chairman, Mr. Arihant Baid, presided over the meeting, which was also attended by directors including Dr. Avasarala Ranga Rao Pantulu and Mr. Sandeep Kumar Daga. The Consolidated Scrutinizer's Report confirming these results has been submitted to the stock exchanges and uploaded on the Company's website.
Historical Stock Returns for Gennex Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.96% | -5.47% | -4.90% | -39.31% | -27.13% | +39.04% |
How might Ms. Khushbu Kachhawa's appointment as Independent Woman Director influence Gennex Laboratories' corporate governance strategy and board-level decision-making going forward?
Given the Chairman's discussion of challenges and opportunities in India's pharma sector, what specific growth initiatives or expansion plans is Gennex Laboratories likely to pursue in the near term?
With only 12.83% of outstanding shares participating in the vote, what steps might Gennex Laboratories take to improve shareholder engagement and retail investor participation in future general meetings?
































